Technology area: Biotechnology & Pharmaceuticals
25 pending office actions • 19 clients • 24 examiners • 23 art units • 0 of 25 (0%) have an AI response strategy ready • 7 patents granted in the last 365 days
This profile has 27 pending office actions in Biotechnology & Pharmaceuticals. Its broader record covers 475 career applications, with a resolved allowance rate of 91.26% and an average of 3.26 office actions per allowance.
The docket shows ongoing prosecution in a biotechnology and pharmaceutical practice. The broader metrics provide context for resolved outcomes and the examination activity associated with allowances, supporting planning for responses and attorney time.
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (4%) |
| §103 only | 7 (28%) |
| §112 only | 1 (4%) |
| Double-patenting + other | 2 (8%) |
| Multi-statute (no §101) | 14 (56%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RAMOS LEWIS, JOSMALEN MILAGROS | 2 | 55.1% | +28.3% |
| ALBERS, KEVIN S | 1 | 25.4% | +50.4% |
| AYALA DELGADO, ANTHONY | 1 | 79.7% | +17.1% |
| NGUYEN, DUSTIN | 1 | 78.4% | +12.6% |
| GATES, BRADFORD M | 1 | 74.8% | +23.8% |
| HINES, LATOSHA D | 1 | 51.4% | +21.6% |
| BRADLEY, CHRISTINA | 1 | 62.6% | +33.3% |
| HOLMES, JUSTIN | 1 | 88.9% | +9.9% |
| CHI, AMANDA LYNN | 1 | — | — |
| HUEBNER, ERICA MICHELLE | 1 | 32.1% | +30.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19441734 | BANDAGE WITH METAL LAYER | ALBERS, KEVIN S | — |
| 19477007 | MULTI-FUEL ENGINE SYSTEM AND METHOD FOR CONTROLLING SAME | AYALA DELGADO, ANTHONY | — |
| 19116527 | SYSTEM AND METHOD FOR CREATING A PRIVATE SERVICE ACCESS NETWORK | NGUYEN, DUSTIN | — |
| 19047284 | PRINT ON MASK AND PRINT ON CORE METHODS FOR 3D PRINTED CIRCUIT STRUCTURES | GATES, BRADFORD M | — |
| 18850815 | PEPTIDE HAVING ANTI-INFLAMMATORY AND ANTI-FIBROTIC ACTIVITIES AND USE THEREOF | BRADLEY, CHRISTINA | — |
| 18887350 | SYSTEM AND METHOD FOR REMOTELY VENDING ITEMS | HOLMES, JUSTIN | — |
| 18805330 | ANIMAL FEEDING APPARATUS | HUEBNER, ERICA MICHELLE | — |
| 18738723 | ELECTRONIC MODULE HAVING A PCB CAP STRUCTURE | SAWYER, STEVEN T | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19067074 | COMBINATION THERAPY FOR THE TREATMENT OF PSYCHIATRIC DISORDER | RAMOS LEWIS, JOSMALEN MILAGROS | 34d |
| 19441734 | BANDAGE WITH METAL LAYER | ALBERS, KEVIN S | — |
| 19477007 | MULTI-FUEL ENGINE SYSTEM AND METHOD FOR CONTROLLING SAME | AYALA DELGADO, ANTHONY | — |
| 19116527 | SYSTEM AND METHOD FOR CREATING A PRIVATE SERVICE ACCESS NETWORK | NGUYEN, DUSTIN | — |
| 19047284 | PRINT ON MASK AND PRINT ON CORE METHODS FOR 3D PRINTED CIRCUIT STRUCTURES | GATES, BRADFORD M | — |
| 18911908 | ISOTOPOLOGUE MARKER FOR FLUID RESOURCES OR POLLUTANTS | HINES, LATOSHA D | — |
| 18850815 | PEPTIDE HAVING ANTI-INFLAMMATORY AND ANTI-FIBROTIC ACTIVITIES AND USE THEREOF | BRADLEY, CHRISTINA | — |
| 18805330 | ANIMAL FEEDING APPARATUS | HUEBNER, ERICA MICHELLE | — |
| Art Unit | Apps |
|---|---|
| 1654 | 2 |
| 1613 | 2 |
| 3786 | 1 |
| 3746 | 1 |
| 2445 | 1 |
| 1621 | 1 |
| 1713 | 1 |
| 1771 | 1 |
| 3655 | 1 |
| 3647 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19441734 | BANDAGE WITH METAL LAYER | Lcp Medical Technologies, LLC | ALBERS, KEVIN S | 3786 | §102§103 | Non-Final OA | — | Pending | Jan 06, 2026 |
| 19477007 | MULTI-FUEL ENGINE SYSTEM AND METHOD FOR CONTROLLING SAME | Hd Hyundai Heavy Industries Co., Ltd. | AYALA DELGADO, ANTHONY | 3746 | §102§103 | Non-Final OA | — | Pending | Oct 20, 2025 |
| 19116527 | SYSTEM AND METHOD FOR CREATING A PRIVATE SERVICE ACCESS NETWORK | Karousels, Inc. | NGUYEN, DUSTIN | 2445 | §102§103 | Non-Final OA | — | Pending | Mar 28, 2025 |
| 19067074 | COMBINATION THERAPY FOR THE TREATMENT OF PSYCHIATRIC DISORDER | Gskb Pharmaceuticals, LLC | RAMOS LEWIS, JOSMALEN MILAGROS | 1621 | §103 | Non-Final OA | 34d | Pending | Feb 28, 2025 |
| 19047284 | PRINT ON MASK AND PRINT ON CORE METHODS FOR 3D PRINTED CIRCUIT STRUCTURES | Lcp Medical Technologies, LLC | GATES, BRADFORD M | 1713 | §103§112 | Non-Final OA | — | Pending | Feb 06, 2025 |
| 18911908 | ISOTOPOLOGUE MARKER FOR FLUID RESOURCES OR POLLUTANTS | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | HINES, LATOSHA D | 1771 | §103 | Non-Final OA | — | Pending | Oct 10, 2024 |
| 18850815 | PEPTIDE HAVING ANTI-INFLAMMATORY AND ANTI-FIBROTIC ACTIVITIES AND USE THEREOF | Caregen Co., Ltd. | BRADLEY, CHRISTINA | 1654 | §102§103 | Non-Final OA | — | Pending | Sep 25, 2024 |
| 18887350 | SYSTEM AND METHOD FOR REMOTELY VENDING ITEMS | Jay'S Tree Care, LLC | HOLMES, JUSTIN | 3655 | §102§103 | Non-Final OA | — | Pending | Sep 17, 2024 |
| 18846541 | A STABLE INJECTABLE COMPOSITION OF TRIAMCINOLONE ACETONIDE | Indoco Remedies Limited | CHI, AMANDA LYNN | 1613 | §103 | Non-Final OA | — | Pending | Sep 12, 2024 |
| 18805330 | ANIMAL FEEDING APPARATUS | Lafayette Bay Products LLC | HUEBNER, ERICA MICHELLE | 3647 | §102§103 | Final Rejection | — | Pending | Aug 14, 2024 |
| 18753210 | ORAL QUETIAPINE SUSPENSION FORMULATIONS WITH EXTENDED SHELF LIFE AND ENHANCED BIOAVAILABILITY | Tlc Therapeutics, LLC | AZPURU, CARLOS A | 1617 | §112DP | Non-Final OA | — | Pending | Jun 25, 2024 |
| 18738723 | ELECTRONIC MODULE HAVING A PCB CAP STRUCTURE | Dsbj Pte. Ltd. | SAWYER, STEVEN T | 2847 | §102§103 | Non-Final OA | — | Pending | Jun 10, 2024 |
| 18633291 | COMBINATION THERAPY FOR THE TREATMENT OF PSYCHIATRIC DISORDER | Gskb Pharmaceuticals, LLC | RAMOS LEWIS, JOSMALEN MILAGROS | 4100 | §103§112 | Non-Final OA | — | Pending | Apr 11, 2024 |
| 18631935 | SUSTAINED RELEASE STABLE EMULSION PHARMACEUTICAL FORMULATIONS | Insitu Biologics, Inc. | CORNET, JEAN P | 1628 | §103§112DP | Non-Final OA | — | Pending | Apr 10, 2024 |
| 18695739 | PEPTIDE HAVING ANTI-INFLAMMATORY ACTIVITY AND USE THEREOF | Caregen Co., Ltd. | HELLMAN, KRISTINA M | 1654 | §102§112 | Non-Final OA | — | Pending | Mar 26, 2024 |
| 18615846 | SUSTAINED RELEASE CANCER THERAPEUTICS FORMULATIONS | Insitu Biologics, Inc. | OLSON, ANDREA STEFFEL | 1693 | §102§103 | Non-Final OA | — | Pending | Mar 25, 2024 |
| 18530154 | NEGATIVE HIGH VOLTAGE ELECTROSTATIC LUBRICANT FILTRATION MINIATURIZATION CONFIGURATION | Elf Holding Company LLC | WILKINS III, HARRY D | 1794 | §102§103§112 | Non-Final OA | — | Pending | Dec 05, 2023 |
| 18247943 | A LIQUID INJECTABLE COMPOSITION OF DONEPEZIL | Pts Consulting, LLC | KENYON, JOHN S | 1625 | §112 | Non-Final OA | — | Pending | Apr 05, 2023 |
| 18176282 | AUTOMATIC DISTRIBUTION OF ACCESS CONTROL CREDENTIALS BASED ON A TASK | Livly, Inc. | SYED, NABIL H | 2689 | §103§112Other | Non-Final OA | — | Pending | Feb 28, 2023 |
| 17965738 | ECHOGENIC COMPOSITIONS AND METHODS OF USE THEREOF FOR THE TREATMENT OF PAIN | Insitu Biologics, Inc. | HOERNER, PAUL ELLSWORTH | 1611 | §103 | Final Rejection | 240d overdue | Pending | Oct 13, 2022 |
| 17758215 | ORAL DISSOLVABLE FILM AND METHOD OF MANUFACTURING AND USING THE SAME | Cure Pharmaceutical Holding Corp. | JANOSKO, CHASITY PAIGE | 1613 | §103 | Final Rejection | 168d overdue | Pending | Jun 29, 2022 |
| 17661216 | FACEPIECE FILTER HAVING OFFSET LAYERED FEATURES | Lcp Medical Technologies, Inc. | SIPPEL, RACHEL T | 3785 | §102§103§112 | Final Rejection | — | Pending | Apr 28, 2022 |
| 17762727 | NUTRITIONAL COMPOSITION FOR VISUAL FUNCTION | Omniactive Health Technologies Limited | HIRAKIS, SOPHIA P | 1623 | §101§103 | Non-Final OA | — | Pending | Mar 22, 2022 |
| 16946999 | TOPICAL COSMETIC | Concept Matrix Solutions | WRIGHT, SARAH C | 1619 | §103 | Non-Final OA | — | Pending | Jul 14, 2020 |
| 16947005 | ORAL DISSOLVABLE FILM CONTAINING PSYCHEDELIC COMPOUND | Concept Matrix Solutions | PARK, HAEJIN S | 1614 | §103 | Non-Final OA | 5d | Pending | Jul 14, 2020 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial91.3% of resolved applications prosecuted by Carlson, Caspers, Vandenburgh & Lindquist, P.A. were allowed, across 475 applications in USPTO records.
3.26 office actions per allowed application on average.
25 pending office actions as of October 2026, for 19 clients, before 24 examiners in 23 art units.
